Results 141 to 150 of about 3,985 (199)
Some of the next articles are maybe not open access.
Progress of immunotherapies in gestational trophoblastic neoplasms
Journal of Cancer Research and Clinical Oncology, 2023Different from other malignant gynecologic tumors, gestational trophoblastic neoplasms (GTNs) exhibit an exceptionally high cure rate primarily through chemotherapeutic interventions. However, there exists a small subset of refractory GTNs that do not respond to conventional chemotherapies.
Tong Wang+6 more
openaire +2 more sources
Gestational trophoblastic neoplasms
Gynecologic Oncology, 1974A review of the classification, biological behavior, clinical diagnosis, and treatment of gestational trophoblastic neoplasms is presented. The events which followed the utilization of chemotherapy as a successful means of therapy are included. Especially important has been the recent recognition that high risk patients, i.e., patients with HCG titers ...
Robert D. Hilgers, John L. Lewis
openaire +3 more sources
Gestational Trophoblastic Neoplasms
Journal of Obstetric, Gynecologic & Neonatal Nursing, 1986Gestational trophoblastic neoplasms have evolved from one of the most rapidly fatal malignancies to potentially one of the most curable, but these diseases have devastating emotional effects on the victims. Etiology, epidemiology, pathophysiology, diagnosis, and medical treatment are reviewed.
Sonya M. Celeste, Maureen D. Smith
openaire +3 more sources
PREGNANCIES AFTER CHEMOTHERAPY OF TROPHOBLASTIC NEOPLASMS
Obstetrical & Gynecological Survey, 1970We have analyzed 88 pregnancies in 50 women who had previously been treated for gestational trophoblastic neoplasms with chemotherapeutic agents. No increase in fetal wastage, congenital abnormalities or complicated pregnancies was noted, suggesting that these drugs do not damage human oocytes in the doses and time periods used.
Griff T. Ross+2 more
openaire +4 more sources
Genetic origin of malignant trophoblastic neoplasms
Cancer Genetics and Cytogenetics, 1994The genetic origin of three trophoblastic neoplasms (two choriocarcinomas and a placental site trophoblast tumor (PSTT)] was determined by analysis of the restriction fragment length polymorphism (RFLP) pattern. One choriocarcinoma, which was believed not illogically to have developed from an antecedent complete mole, contained both paternal and ...
Masazumi Tsuneyoshi+4 more
openaire +3 more sources
Intermediate Trophoblast in Germ Cell Neoplasms
The American Journal of Surgical Pathology, 1987One-hundred-twenty-four germ cell tumors and 11 gestational choriocarcinomas were assessed immunohistochemically for the presence of the following placental markers: human chorionic gonadotrophin, human placental lactogen, and pregnancy-specific beta-1 glycoprotein, and for the expression of cytokeratin.
G. Niehans+3 more
openaire +3 more sources
Primary chemotherapy for nonmetastatic gestational trophoblastic neoplasms
American Journal of Obstetrics and Gynecology, 1967Abstract This report summarizes our 7 years' experience in the methotrexate chemotherapy of 58 patients with nonmetastatic gestational trophoblastic neoplasms. Of these patients, 54 (93 per cent) entered sustained complete remission. Three of the remaining 4 patients with methotrexate-resistant disease later entered remission with either hysterectomy
Griff T. Ross+4 more
openaire +3 more sources
Modified Bagshawe Regimen for Gestational Trophoblastic Neoplasms [PDF]
The increasing complexity of cancer chemotherapy heightens the requirement that pharmacists be familiar with these highly toxic agents. This column will review various issues related to preparation, dispensing, and administration of cancer chemotherapy.
J. Aubrey Waddell+2 more
openaire +1 more source
Gestational Trophoblastic Neoplasms:
Obstetrics and Gynecology Clinics of North America, 1988Gestational trophoblastic neoplasms have been recognized since 1600 AD. This article briefly reviews the history of this distinctive disease and highlights some interesting features.
openaire +3 more sources